Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Entrada Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 53 | 56 | +3 |
| Shares | 24.9M | 25.8M | +863.0K (+3.5%) |
| Value | $361.0M | $389.9M | +$28.8M (+8.0%) |
New holders (15)
Institutions that held Entrada Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| American Century Companies Inc | 24,787 | $375.3K | 0.00% |
| Rhumbline Advisers | 24,219 | $366.7K | 0.00% |
| Corton Capital Inc. | 18,067 | $273.5K | 0.13% |
| MetLife Investment Management | 11,694 | $177.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,874 | $164.6K | 0.00% |
| American International Group, Inc. | 10,299 | $155.9K | 0.00% |
| New York State Common Retirement Fund | 8,700 | $131.7K | 0.00% |
| Deutsche Bank AG | 8,506 | $128.8K | 0.00% |
| Russell Investments Group, Ltd. | 6,753 | $102.2K | 0.00% |
| STRS Ohio | 2,700 | $40.0K | 0.00% |
| Lazard Asset Management LLC | 2,417 | $36.0K | 0.00% |
| Royal Bank of Canada | 2,233 | $34.0K | 0.00% |
| Amalgamated Bank | 2,081 | $32.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,767 | $26.8K | 0.00% |
| Metropolitan Life Insurance Co | 1,212 | $18.4K | 0.00% |
Sold out (12)
Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Laurion Capital Management LP | 199,066 | $2.89M |
| Susquehanna International Group, LLP | 196,513 | $2.85M |
| Jane Street Group, LLC | 73,898 | $1.07M |
| CHI Advisors LLC | 56,374 | $817.4K |
| Qube Research & Technologies Ltd | 38,782 | $562.3K |
| HRT Financial LP | 38,395 | $556.0K |
| LMR Partners LLP | 13,023 | $188.8K |
| 683 Capital Management, LLC | 10,355 | $150.1K |
| Y-Intercept (Hong Kong) Ltd | 10,188 | $147.7K |
| Cubist Systematic Strategies, LLC | 4,160 | $60.3K |
| Point72 Middle East FZE | 3,441 | $49.9K |
| Point72 Asset Management, L.P. | 2,840 | $41.2K |